Antifungal agents: spectrum of activity, pharmacology, and clinical indications

JE Nett, DR Andes - Infectious Disease Clinics, 2016 - id.theclinics.com
Continued advancement of medical science offers life-saving treatment options for a variety
of hematologic, oncologic, and rheumatologic conditions. Immunosuppression, a common …

The biology and chemistry of antifungal agents: a review

MK Kathiravan, AB Salake, AS Chothe… - Bioorganic & medicinal …, 2012 - Elsevier
In recent years their has been an increased use of antifungal agents and has resulted in the
development of resistance to drugs. Currently, use of standard antifungal therapies can be …

High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis

B Zhai, M Ola, T Rolling, NL Tosini, S Joshowitz… - Nature medicine, 2020 - nature.com
The intestinal microbiota is a complex community of bacteria, archaea, viruses, protists and
fungi,. Although the composition of bacterial constituents has been linked to immune …

Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology

LR Baden, S Swaminathan, M Angarone… - Journal of the National …, 2016 - jnccn.org
Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America

AG Freifeld, EJ Bow, KA Sepkowitz… - Clinical infectious …, 2011 - academic.oup.com
This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …

[HTML][HTML] Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …

8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients …

AH Groll, D Pana, F Lanternier, A Mesini… - The Lancet …, 2021 - thelancet.com
Paediatric patients with cancer and those undergoing allogeneic haematopoietic cell
transplantation have an increased susceptibility to invasive fungal diseases. In addition to …

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

OA Cornely, J Maertens, DJ Winston… - … England Journal of …, 2007 - Mass Medical Soc
Background Patients with neutropenia resulting from chemotherapy for acute myelogenous
leukemia or the myelodysplastic syndrome are at high risk for difficult-to-treat and often fatal …

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance

TC White, KA Marr, RA Bowden - Clinical microbiology reviews, 1998 - Am Soc Microbiol
In the past decade, the frequency of diagnosed fungal infections has risen sharply due to
several factors, including the increase in the number of immunosuppressed patients …

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

AJ Ullmann, JH Lipton, DH Vesole… - … England Journal of …, 2007 - Mass Medical Soc
Background Invasive fungal infections are an important cause of morbidity and mortality after
allogeneic hematopoietic stem-cell transplantation. Methods In an international …